Tumor cell ligands for NK cell activating and death receptors (NK/DR Ligands)

Tumor cell ligands recognized by Natural Killer (NK) cell activating receptors (NKp30, NKp44, NKp46, NKG2D) and death receptors (such as Fas and TRAIL-R1/2) represent a diverse group of surface proteins that serve as critical signals for immune-mediated destruction of malignant cells (Raulet et al., 2013, Nat Rev Immunol). Key examples include B7-H6, which specifically binds NKp30, and the MHC class I-like molecules MICA, MICB, and ULBP1-6, which engage the NKG2D receptor (Brandt et al., 2009, J Exp Med). These ligands are typically upregulated in response to cellular stressors such as DNA damage, oxidative stress, or oncogenic transformation, effectively marking the cell for elimination by NK cells and cytotoxic T lymphocytes. Additionally, ligands for death receptors, such as TRAIL and FasL, can directly trigger extrinsic apoptotic pathways upon binding to their respective receptors on the tumor cell surface (Ashkenazi, 2008, Nat Rev Drug Discov). In therapeutic development, these ligands are targeted through various modalities, including agonistic antibodies designed to trigger death receptors or bispecific engagers that bridge NK cells to ligand-expressing tumor cells. Chimeric Antigen Receptor (CAR) therapies, such as those utilizing the NKG2D extracellular domain, are also being explored to target the broad range of NKG2D ligands expressed across multiple tumor types (Leung, 2020, Front Immunol). However, a significant challenge in targeting these molecules is the phenomenon of ligand shedding, where tumor cells proteolytically release soluble forms of the ligands (e.g., sMICA) to act as decoys, thereby neutralizing receptor activity and facilitating immune evasion (Groh et al., 2002, Nature). Clinical success depends on overcoming these evasion mechanisms and managing potential toxicities, such as the hepatotoxicity observed with early-generation death receptor agonists.

Other names

NKG2D ligandsNatural cytotoxicity receptor ligandsNCR ligandsPro-apoptotic receptor ligandsStress-induced ligandsMICA/B and ULBPsB7-H6

Induction of apoptosis via death receptor agonism or activation of NK cell-mediated cytotoxicity through engagement of activating receptors.